ICAHN CARL C
Institutional investor · Portfolio as of Q1 2025
Top Holdings14 positions
ICAHN ENTERPRISES LP | 450.8M | $4.1B | 54.5% | $14.15 | -55.45% | 26 qtrssince 2018-Q4 | Unchanged 0 |
CVR ENERGY INC | 68.5M | $1.3B | 17.8% | $19.52 | -1.20% | 26 qtrssince 2018-Q4 | Increased 67 |
Southwest Gas Holdings Inc | 7.5M | $540.8M | 7.2% | $62.21 | +14.43% | 15 qtrssince 2021-Q3 | Decreased 0 |
CVR PARTNERS LP | 4.1M | $308.1M | 4.1% | $59.20 | +4.48% | 5 qtrssince 2024-Q1 | Increased 60 |
International Flavors & Fragra | 3.8M | $291M | 3.9% | $87.62 | -14.38% | 13 qtrssince 2022-Q1 | Unchanged 0 |
Valeant Pharmaceuticals Intern | 34.7M | $224.6M | 3.0% | $29.39 | -77.95% | 18 qtrssince 2020-Q4 | Unchanged 0 |
Dana Inc | 14.3M | $190.4M | 2.5% | $20.31 | +44.45% | 18 qtrssince 2020-Q4 | Unchanged 0 |
JetBlue Airways Corp | 33.6M | $162.1M | 2.2% | $6.19 | -22.14% | 5 qtrssince 2024-Q1 | Increased 85 |
American Electric Power Co Inc | 1.2M | $131.7M | 1.8% | $73.72 | +41.33% | 6 qtrssince 2023-Q4 | Unchanged 0 |
Eldorado Resorts Inc | 2.4M | $61M | 0.8% | $39.74 | -35.41% | 4 qtrssince 2024-Q2 | Unchanged 0 |
SandRidge Energy Inc | 4.8M | $55M | 0.7% | $5.53 | +100.36% | 26 qtrssince 2018-Q4 | Unchanged 0 |
Bausch Lomb Corp | 3.5M | $50.8M | 0.7% | $15.28 | -7.53% | 12 qtrssince 2022-Q2 | Unchanged 0 |
CENTURI HOLDINGS INC | 2.5M | $40.8M | 0.5% | $18.33 | -9.67% | 4 qtrssince 2024-Q2 | Unchanged 0 |
Illumina Inc | 220,000 | $17.5M | 0.2% | $105.29 | +164.18% | 9 qtrssince 2023-Q1 | Increased 58 |
ICAHN CARL C manages $7.5B across 14 positions as of Q1 2025. Top holdings: IEP (54.5%), CVI (17.8%), SWX (7.2%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Increased 4, trimmed 1. Top move: JBLU (INCREASED, conviction 85). Portfolio: $7.5B across 14 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR